Acadia Pharmaceuticals Stock Investor Sentiment

ACAD Stock  USD 19.00  0.01  0.05%   
About 55% of ACADIA Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding ACADIA Pharmaceuticals suggests that many traders are impartial. The current market sentiment, together with ACADIA Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use ACADIA Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at investing.com         
Acadia Pharmaceuticals principal accounting officer sells shares worth 68,467
Investing News at Macroaxis
over three months ago at investing.com         
Acadia Pharmaceuticals CFO sells shares worth 172,453
Investing News at Macroaxis
over three months ago at gurufocus.com         
Disposition of 10259 shares by Mark Schneyer of ACADIA Pharmaceuticals at 16.81 subject to Rule 16b-...
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
ACADIA HEALTHCARE ALERT Bragar Eagel Squire, P.C. ...
Gurufocus Stories at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 9913 shares by Mark Schneyer of ACADIA Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over three months ago at prnewswire.com         
ACADIA HEALTHCARE SHAREHOLDER ALERT CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF 100,000 o...
prnewswire News
over three months ago at businesswire.com         
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over three months ago at businesswire.com         
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over three months ago at thelincolnianonline.com         
ACADIA Pharmaceuticals Downgraded to Buy Rating by StockNews.com
news
over three months ago at investing.com         
ACADIA Pharmaceuticals SWOT analysis mixed results for CNS drug stock
Investing News at Macroaxis
over three months ago at zacks.com         
Heres Why Acadia Pharmaceuticals is a Strong Momentum Stock
zacks News
over three months ago at thelincolnianonline.com         
WCM Investment Management LLC Has 4.50 Million Holdings in ACADIA Pharmaceuticals Inc.
news
over three months ago at thelincolnianonline.com         
What is Leerink Partnrs Forecast for ACAD FY2026 Earnings?
news
over three months ago at prnewswire.com         
ACADIA HEALTHCARE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL KAHN SWICK FOTI, LLC REMIND...
prnewswire News
over three months ago at insidermonkey.com         
ACADIA Pharmaceuticals Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
Far too much social signal, news, headlines, and media speculation about ACADIA Pharmaceuticals that are available to investors today. That information is available publicly through ACADIA media outlets and privately through word of mouth or via ACADIA internal channels. However, regardless of the origin, that massive amount of ACADIA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ACADIA Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ACADIA Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ACADIA Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ACADIA Pharmaceuticals alpha.

ACADIA Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for ACADIA Stock analysis

When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance